Literature DB >> 24357594

De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg syndrome: two new cases and a clinical review.

P Y Billie Au1, Hilary E Racher, John M Graham, Nancy Kramer, R Brian Lowry, Jillian S Parboosingh, A Micheil Innes.   

Abstract

Shprintzen-Goldberg syndrome (OMIM #182212) is a connective tissue disorder characterized by craniosynostosis, distinctive craniofacial features, skeletal abnormalities, marfanoid body habitus, aortic dilatation, and intellectual disability. Mutations in exon 1 of SKI have recently been identified as being responsible for approximately 90% of reported individuals diagnosed clinically with Shprintzen-Goldberg syndrome. SKI is a known regulator of TGFβ signaling. Therefore, like Marfan syndrome and Loeys-Dietz syndrome, Shprintzen-Goldberg syndrome is likely caused by deregulated TGFβ signals, explaining the considerable phenotypic overlap between these three disorders. We describe two additional patients with exon 1 SKI mutations and review the clinical features and literature of Shprintzen-Goldberg syndrome.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Loeys-Dietz; Marfan; SKI protein; Shprintzen-Goldberg; aortic diseases; craniosynostosis; human; transforming growth factor beta

Mesh:

Substances:

Year:  2013        PMID: 24357594     DOI: 10.1002/ajmg.a.36340

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK.

Authors:  P Y Billie Au; Jing You; A Micheil Innes; Antonie D Kline; Oana Caluseriu; Jeremy Schwartzentruber; Jacek Majewski; Francois P Bernier; Marcia Ferguson; David Valle; Jillian S Parboosingh; Nara Sobreira
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

2.  The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome.

Authors:  Dorien Schepers; Alexander J Doyle; Gretchen Oswald; Elizabeth Sparks; Loretha Myers; Patrick J Willems; Sahar Mansour; Michael A Simpson; Helena Frysira; Anneke Maat-Kievit; Rick Van Minkelen; Jeanette M Hoogeboom; Geert R Mortier; Hannah Titheradge; Louise Brueton; Lois Starr; Zornitza Stark; Charlotte Ockeloen; Charles Marques Lourenco; Ed Blair; Emma Hobson; Jane Hurst; Isabelle Maystadt; Anne Destrée; Katta M Girisha; Michelle Miller; Harry C Dietz; Bart Loeys; Lut Van Laer
Journal:  Eur J Hum Genet       Date:  2014-04-16       Impact factor: 4.246

3.  Deciphering the Pathogenic Nature of Two de novo Sequence Variations in a Patient with Shprintzen-Goldberg Syndrome.

Authors:  Priyanka Srivastava; Shashank Shende; Kausik Mandal
Journal:  Mol Syndromol       Date:  2021-05-06

4.  Complications of Insufficient Dura and Blood Loss During Surgical Intervention in Shprintzen-Goldberg Syndrome: A Case Report.

Authors:  Gabrielle R O'Dougherty; Daniel H Fulkerson; Melissa Kern; Kasturi Haldar; Barbara Calhoun
Journal:  Am J Case Rep       Date:  2019-08-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.